169 related articles for article (PubMed ID: 25501835)
21. Therapeutic effects of uterine artery embolisation (UAE) and methotrexate (MTX) conservative therapy used in treatment of cesarean scar pregnancy.
Yang H; Li S; Ma Z; Jia Y
Arch Gynecol Obstet; 2016 Apr; 293(4):819-23. PubMed ID: 26386965
[TBL] [Abstract][Full Text] [Related]
22. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
El-Bialy G; Kassab A; Armstrong M
Arch Gynecol Obstet; 2007 Oct; 276(4):371-3. PubMed ID: 17356825
[TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis: Conservative treatment of placenta increta with methotrexate.
Zhang C; Li H; Zuo C; Wang X
J Obstet Gynaecol Res; 2018 May; 44(5):907-913. PubMed ID: 29484784
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation.
Chou MM; Yuan JC; Lu YA; Chuang SW
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):952-955. PubMed ID: 33218420
[TBL] [Abstract][Full Text] [Related]
25. Management of Abnormal Placenta Implantation with Methotrexate: A Review of Published Data.
Farasatinasab M; Moghaddas A; Dashti-Khadivaki S; Raoofi Z; Nasiripour S
Gynecol Obstet Invest; 2016; 81(6):481-496. PubMed ID: 27384687
[TBL] [Abstract][Full Text] [Related]
26. Conservative endovascular management of retained placenta accreta with marked vascularity after abortion or delivery.
Takeda A; Koike W
Arch Gynecol Obstet; 2017 Dec; 296(6):1189-1198. PubMed ID: 28980065
[TBL] [Abstract][Full Text] [Related]
27. Conservative treatment of placenta increta with methotrexate.
Crespo R; Lapresta M; Madani B
Int J Gynaecol Obstet; 2005 Nov; 91(2):162-3. PubMed ID: 16126207
[No Abstract] [Full Text] [Related]
28. Uterine artery embolization combined with local methotrexate and systemic methotrexate for treatment of cesarean scar pregnancy with different ultrasonographic pattern.
Lian F; Wang Y; Chen W; Li J; Zhan Z; Ye Y; Zhu Y; Huang J; Xu H; Yang X; Liang L; Yang J
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):286-91. PubMed ID: 21271248
[TBL] [Abstract][Full Text] [Related]
29. High-intensity focused ultrasound combined procedures treatment of retained placenta accreta with marked vascularity after abortion or delivery.
Jiang X; Tang Q; Yang B; Ye F; Cai L; Wang X; Luo X; Bu H
Int J Hyperthermia; 2019; 36(1):421-427. PubMed ID: 30892148
[TBL] [Abstract][Full Text] [Related]
30. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound.
Chou MM; Ho ES; Lee YH
Ultrasound Obstet Gynecol; 2000 Jan; 15(1):28-35. PubMed ID: 10776009
[TBL] [Abstract][Full Text] [Related]
31. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques.
Shih JC; Palacios Jaraquemada JM; Su YN; Shyu MK; Lin CH; Lin SY; Lee CN
Ultrasound Obstet Gynecol; 2009 Feb; 33(2):193-203. PubMed ID: 19173239
[TBL] [Abstract][Full Text] [Related]
32. The use of methotrexate in conservative treatment of placenta accreta spectrum disorders.
Gregoir C; De Becker B; Hauspy J; Vanderheyden T; Loquet P
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7514-7517. PubMed ID: 34278931
[No Abstract] [Full Text] [Related]
33. Accuracy of ultrasound in antenatal diagnosis of placental attachment disorders.
Pilloni E; Alemanno MG; Gaglioti P; Sciarrone A; Garofalo A; Biolcati M; Botta G; Viora E; Todros T
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):302-7. PubMed ID: 25964123
[TBL] [Abstract][Full Text] [Related]
34. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
[TBL] [Abstract][Full Text] [Related]
35. Uterine Artery Embolization Versus Methotrexate for Cesarean Scar Pregnancy in a Chinese Population: A Meta-analysis.
Qiao B; Zhang Z; Li Y
J Minim Invasive Gynecol; 2016; 23(7):1040-1048. PubMed ID: 27553186
[TBL] [Abstract][Full Text] [Related]
36. High-intensity focused ultrasound treatment of placenta accreta after vaginal delivery: a preliminary study.
Bai Y; Luo X; Li Q; Yin N; Fu X; Zhang H; Qi H
Ultrasound Obstet Gynecol; 2016 Apr; 47(4):492-8. PubMed ID: 25846712
[TBL] [Abstract][Full Text] [Related]
37. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
[TBL] [Abstract][Full Text] [Related]
38. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
[TBL] [Abstract][Full Text] [Related]
39. Log-linear human chorionic gonadotropin elimination in cases of retained placenta percreta.
Stitely ML; Gerard Jackson M; Holls WH
Arch Gynecol Obstet; 2014 Feb; 289(2):259-62. PubMed ID: 23843154
[TBL] [Abstract][Full Text] [Related]
40. Uterine artery embolisation combined with local methotrexate for treatment of caesarean scar pregnancy.
Yang XY; Yu H; Li KM; Chu YX; Zheng A
BJOG; 2010 Jul; 117(8):990-6. PubMed ID: 20536432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
